La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Beyond Air Croissance future
Future contrôle des critères 2/6
Beyond Air is forecast to grow earnings and revenue by 50.1% and 58% per annum respectively while EPS is expected to grow by 54.4% per annum.
Informations clés
50.1%
Taux de croissance des bénéfices
54.4%
Taux de croissance du BPA
| Medical Equipment croissance des bénéfices | 17.4% |
| Taux de croissance des recettes | 58.0% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 16 Aug 2024 |
Mises à jour récentes de la croissance future
Recent updates
We're Keeping An Eye On Beyond Air's (NASDAQ:XAIR) Cash Burn Rate
Apr 05
Will Beyond Air (NASDAQ:XAIR) Spend Its Cash Wisely?
Dec 14Beyond Air presents pilot at-home study data; stock earlier snaps 7-day losing streak
Oct 17Beyond Air: Bottom Line Fundamentals Keep Buyers At Bay
Sep 08Beyond Air affiliate Beyond Cancer doses patient in phase 1 study of ultra-high concentration nitric oxide therapy
Aug 23Beyond Air reaches six-month high after $2.3M insider transactions
Jul 06Companies Like Beyond Air (NASDAQ:XAIR) Are In A Position To Invest In Growth
May 02Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 3/31/2027 | 64 | -16 | N/A | N/A | 4 |
| 3/31/2026 | 32 | -36 | N/A | N/A | 5 |
| 3/31/2025 | 9 | -49 | N/A | N/A | 5 |
| 6/30/2024 | 2 | -58 | -57 | -49 | N/A |
| 3/31/2024 | 1 | -60 | -62 | -56 | N/A |
| 12/31/2023 | 1 | -67 | -60 | -54 | N/A |
| 9/30/2023 | 0 | -63 | -54 | -48 | N/A |
| 6/30/2023 | 0 | -59 | -48 | -43 | N/A |
| 3/31/2023 | N/A | -56 | -37 | -33 | N/A |
| 12/31/2022 | N/A | -56 | -35 | -32 | N/A |
| 9/30/2022 | N/A | -51 | -32 | -30 | N/A |
| 6/30/2022 | N/A | -47 | -28 | -26 | N/A |
| 3/31/2022 | N/A | -43 | -25 | -23 | N/A |
| 12/31/2021 | 0 | -28 | -22 | -21 | N/A |
| 9/30/2021 | 0 | -26 | -21 | -20 | N/A |
| 6/30/2021 | 1 | -23 | -19 | -18 | N/A |
| 3/31/2021 | 1 | -23 | -21 | -20 | N/A |
| 12/31/2020 | 1 | -23 | -20 | -19 | N/A |
| 9/30/2020 | 1 | -22 | -19 | -18 | N/A |
| 6/30/2020 | 1 | -21 | -18 | -18 | N/A |
| 3/31/2020 | 1 | -20 | -15 | -15 | N/A |
| 12/31/2019 | 9 | -15 | -3 | -3 | N/A |
| 9/30/2019 | 9 | -13 | 0 | 0 | N/A |
| 6/30/2019 | 8 | -11 | 1 | 1 | N/A |
| 3/31/2019 | 8 | -7 | 1 | 1 | N/A |
| 12/31/2018 | N/A | -5 | -8 | -7 | N/A |
| 9/30/2018 | N/A | -5 | -8 | -8 | N/A |
| 6/30/2018 | N/A | -10 | -7 | -7 | N/A |
| 3/31/2018 | N/A | -11 | N/A | -7 | N/A |
| 12/31/2017 | N/A | -18 | N/A | -7 | N/A |
| 9/30/2017 | N/A | -17 | N/A | -6 | N/A |
| 6/30/2017 | N/A | -11 | N/A | -4 | N/A |
| 3/31/2017 | N/A | -9 | N/A | -3 | N/A |
| 12/31/2016 | N/A | -4 | N/A | -1 | N/A |
| 9/30/2016 | N/A | -3 | N/A | -1 | N/A |
| 6/30/2016 | N/A | -4 | N/A | -1 | N/A |
| 3/31/2016 | N/A | -4 | N/A | -1 | N/A |
| 12/31/2015 | N/A | -4 | N/A | -2 | N/A |
| 9/30/2015 | N/A | -4 | N/A | -2 | N/A |
| 6/30/2015 | N/A | -4 | N/A | -2 | N/A |
| 3/31/2015 | N/A | -4 | N/A | -2 | N/A |
| 12/31/2014 | N/A | -5 | N/A | -2 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: XAIR is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: XAIR is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: XAIR is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: XAIR's revenue (58% per year) is forecast to grow faster than the US market (8.8% per year).
Croissance élevée des revenus: XAIR's revenue (58% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if XAIR's Return on Equity is forecast to be high in 3 years time